Thanks golf,

With such great publication verification for apabetalone as a standout epigenetic  therapy for many diseases. what is keeping BP way from this ??? To say that it can impede on their existing drugs is an argument as Apabetalone can be used as combo to their drugs and extend their patents and extend the life of their drugs.  IF a BP was on board the BETONMACE2  trial would be expediated and would give instant credibility to RVX.  i doubt will get any fantastic news at the AGM but who knows with management team